Advertisement
Advertisement
Business /

Investor Relations

China's top two chipmakers saw their revenues and profits surge in the second quarter amid high demand for AI chips. Photo: Shutterstock
Semiconductors

Chinese chip foundries surge as AI boom drives triple-digit profit growth

SMIC, Hua Hong Grace results highlight how local foundries are aggressively running their plants at full capacity to meet domestic needs.

Hong Kong property

CK Hutchison Holdings reports 31-fold surge in first-half profit

Artificial intelligence

The ‘rice of electronics’: AI boom is fuelling China’s MLCC supply chain

Ant Group

Ant Group spin-offs pursue independent growth with strategic capital moves

The Chinese fintech giant’s three spin-off units are accelerating their capital-raising efforts after gaining operational autonomy in 2024.

The Ant Group booth at the World Artificial Intelligence Conference in Shanghai on July 17, 2026. Photo: Reuters
The Ant Group booth at the World Artificial Intelligence Conference in Shanghai on July 17, 2026. Photo: Reuters
Banking & finance

Standard Chartered posts 10% profit rise, launches US$1b buy-back

Share price surges on 38 per cent rise in wealth-management revenue, even as Middle East tensions and bad debt temper profit growth.

videocam
Alibaba

From CXMT to Zhipu AI, Alibaba’s strategic investments are paying off

The company’s strategic shift to AI and chip investments is not only yielding significant returns, but also boosting its tech portfolio.

Advertisement
Advertisement
Advertisement
China’s private sector

‘Historic breakthrough’: China approves novel drug ahead of US, Japan and Europe

Push to accelerate novel drug reviews promises earlier access to breakthrough therapies for patients long left waiting.

China is pushing to accelerate novel drug reviews. Photo: Shutterstock
China is pushing to accelerate novel drug reviews. Photo: Shutterstock
Banking & finance

Healthcare IPO wave: US biotech firm picks Hong Kong over Nasdaq for listing

Axiom Biosciences founder says Hong Kong investors show greater maturity than Nasdaq in handling biotech companies.

Semiconductors

CXMT’s mega IPO draws frenzy from retail investors to DeepSeek founder’s fund

Investors are hoping for a relatively generous allotment rate and sharp gains when the memory-chip maker debuts on Shanghai’s Star Market.

China’s private sector

Europe beckons: can Chinese medical device makers thrive amid trade barriers?

Chinese medical device companies eye Europe for relief from hospital probes at home while navigating protectionism overseas.

Fiscal pressure has made European governments more receptive to Chinese medical devices in recent years. Photo: Xinhua
China’s private sector

Can AI collaborations power China’s next wave of blockbuster drug deals?

China develops 30 per cent of new therapies worldwide as it rises to the top tier in innovation efficiency, drug supervision official says.

A pharmaceutical manufacturing line. Photo: Shutterstock
A pharmaceutical manufacturing line. Photo: Shutterstock
Banking & finance

Hong Kong exchange lures listings from Canada, Indonesia, Kazakhstan

Bourse expected to see influx of international issuers in year’s second half, led by consumer goods and services companies, according to PwC.

Banking & finance

‘Big Short’ 2.0? US hedge fund manager warns of a global AI bubble

China’s AI stocks entered the second half of 2026 with improving earnings momentum, but scepticism about the sector is increasing.

Hong Kong stock market

China’s tax crackdown: A-share and Hong Kong-listed firms hit hard

Beijing’s anti-tax evasion campaign could expand, raising concerns that corporate earnings, cash flows and investor sentiment may be at risk.

BeOne Medicine's manufacturing site in Guangzhou. The company's Chinese subsidiary has agreed to pay 446 million yuan (US$65.6 million) after receiving a notice from a local tax authority. Photo: Handout
IPO

Hong Kong loses IPO crown as swelling wave of Chinese tech no match for SpaceX

With Chinese technology giants fuelling an ‘A-to-H’ listing boom, Hong Kong appears to be on the rise as their ‘fundraising venue of choice’.

videocam
A gong is struck to mark the HKEX’s 26th anniversary at Connect Hall on Friday. Photo: May Tse
A gong is struck to mark the HKEX’s 26th anniversary at Connect Hall on Friday. Photo: May Tse
Banking & finance

Hong Kong’s IPO Connect push: why investors see it as the next frontier

Calls grow to further expand Hong Kong’s connect scheme with mainland China markets amid drive for deeper capital flows.

IPO

Momenta granted regulatory approval to list in Hong Kong amid rumoured crackdown

As Beijing appears to tighten rules on the listing of domestic firms incorporated offshore, self-driving tech start-up Momenta gains IPO approval.

videocam
Advertisement
Advertisement
Advertisement
China’s private sector

Bigger, fewer, tougher: the new era of China-US biotech partnerships

China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.

In focus: Chinese biotech firms such as Jiangsu Hengrui Pharmaceutical are navigating growing geopolitical scrutiny as cross-border licensing deals continue to expand. Photo: Shutterstoc
In focus: Chinese biotech firms such as Jiangsu Hengrui Pharmaceutical are navigating growing geopolitical scrutiny as cross-border licensing deals continue to expand. Photo: Shutterstoc
Hong Kong stock market

Lenovo targets US$2b bond to repurchase debt amid AI infrastructure growth

World’s largest PC maker plans to use the proceeds to buy back shares and strengthen its financial position amid sustained growth.

IPO

Mainland China theme park operator applies for listing in Hong Kong

Company operates Millennium City Park in Kaifeng, a life-size recreation of a famous painting from the Northern Song dynasty.

China Evergrande Group

China Evergrande liquidators seek judicial review of SFC agreement with PwC HK

Failed developer’s creditors have been made HK$1 billion worse off by the agreement, liquidators say.

Residents walk through a partially shuttered China Evergrande commercial complex in Beijing on January 29, 2024 - the same day the firm was ordered to liquidate by a Hong Kong court. Photo: AP
China’s private sector

China biotech firms say global push is ‘irreversible’ despite US barriers

Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.

Chinese companies now account for about half of all global biotechnology business development deals. Photo: Shutterstock
Chinese companies now account for about half of all global biotechnology business development deals. Photo: Shutterstock
Electric & new energy vehicles

BYD playing catch-up with demand for fast-charging batteries

Carmaker says sales volume this year will be limited by battery production, which it is expanding by 20,000 to 30,000 units per month.

China’s private sector

With AI able to predict disease, can we treat ageing like a ‘bug’ in the system?

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks.

Hong Kong Monetary Authority (HKMA)

Mainland investors face uncertainty amid regulatory crackdown

Tighter overseas investment rules are leading some investors to shift to mainland-approved channels as Hong Kong brokers restrict access.

Online brokerage Tiger Brokers announced on Tuesday that it would restrict account and trading access for mainland investors amid tightening scrutiny of cross-border capital flows. Photo: Handout
Help preserve 120 years of quality journalism.
SUPPORT NOW